Tiziana Life Sciences

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell TLSA and other ETFs, options, and stocks.

About TLSA

Tiziana Life Sciences Ltd. is a clinical-stage biotechnology company, which engages in developing therapies for neurodegenerative and lung diseases. Its clinical pipeline includes drug assets for Secondary Progressive Multiple Sclerosis, Amyotrophic Lateral Sclerosis, and Alzheimer’s.

CEO

Ivor Elrifi

CEOIvor Elrifi

Employees

Employees9

Headquarters

London, Greater London

HeadquartersLondon, Greater London

Founded

1998

Founded1998

Employees

Employees9

TLSA Key Statistics

Market cap

141.65M

Market cap141.65M

Price-Earnings ratio

—

Price-Earnings ratio—

Dividend yield

—

Dividend yield—

Average volume

869.07K

Average volume869.07K

High today

$1.41

High today$1.41

Low today

$1.25

Low today$1.25

Open price

$1.37

Open price$1.37

Volume

538.73K

Volume538.73K

52 Week high

$1.91

52 Week high$1.91

52 Week low

$0.41

52 Week low$0.41

Tiziana Life Sciences

Why Robinhood?

Tiziana Life Sciences Ltd. is a clinical-stage biotechnology company, which engages in developing therapies for neurodegenerative and lung diseases. Its clinical pipeline includes drug assets for Secondary Progressive Multiple Sclerosis, Amyotrophic Lateral Sclerosis, and Alzheimer’s. Show more

TLSA Key Statistics

Tiziana Life Sciences Ltd. is a clinical-stage biotechnology company, which engages in developing therapies for neurodegenerative and lung diseases. Its clinical pipeline includes drug assets for Secondary Progressive Multiple Sclerosis, Amyotrophic Lateral Sclerosis, and Alzheimer’s.